More patients achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg systolic blood pressure with semaglutide versus comparators (SUSTAIN 1–5, 7)

Discipline: 
Diabetes
Clinical taxonomy: 
Treatments for diabetes
Resource taxonomy: 
Event resources
Abstracts

Information for HCPs

COVID-19 Information for Healthcare Professionals